I ran this through Google translate, you're welcome:
"demonstrated a sub-optimal safety profile" = every mouse injected grew tentacles from their spleens and started speaking Russian.
"Following a review of over 200 available compounds" = holy crap what do we do now, quick look under the couch someone
"a closely related analogue" = we have this sludge left in the test tube after making all that NYR-BI02....
"a superior safety profile" = tastes a bit like chicken actually
"commencing the preclinical, TBI efficacy and stroke model studies in the second half of this year" = And we are on track to be in the clinic sometime in Q3 2054.
Ann: Brain Injury Program Preclinical Development Update, page-7
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.005(4.55%) |
Mkt cap ! $20.95M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 12.0¢ | 11.0¢ | $164.0K | 1.456M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 742920 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 254495 | 3 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| NYR (ASX) Chart |